Document is current
Any future updates will be listed below
-
Authors
Clelland, Claire Dudley https://orcid.org/0000-0002-9112-2278
Fan, Li https://orcid.org/0000-0003-1780-6919
Saloner, Rowan https://orcid.org/0000-0002-1351-6183
Etchegaray, Jon Iker
Altobelli, Chad Richard
Salomonsson, Sally
Maltos, Alisha M. https://orcid.org/0000-0001-6631-481X
Sachdev, Aradhana
Zhu, Jingjie
Lee, Se-In
Li, Yaqiao
Zhou, Yungui
Le, David
Wang, Chao
Carling, Gillian https://orcid.org/0000-0002-1504-1716
Kodama, Lay
Sayed, Faten https://orcid.org/0000-0003-3992-4668
Perez-Bermejo, Jaun A.
Geier, Ethan G.
Yokoyama, Jennifer S. https://orcid.org/0000-0001-7274-2634
Rosen, Howie
Nana, Alissa L. https://orcid.org/0000-0003-3474-8044
Spina, Salvatore https://orcid.org/0000-0003-3570-9143
Grinberg, Lea T. https://orcid.org/0000-0002-6809-0618
Seeley, William W. https://orcid.org/0000-0003-1410-2027
Elahi, Fanny
Boxer, Adam L.
Arkin, Michelle R. https://orcid.org/0000-0002-9366-6770
- License Information
-
More Information
Article History
Received: 14 November 2023
Accepted: 10 June 2025
First Online: 1 July 2025
Competing interests
: C.D.C. is a founder, with equity, in Ciznor Co. L.G. is founder and equity holder of Aeton Therapeutics Inc. S.Sp. received consulting honoraria from Techspert.io, Precision Xtract, Acsel Health, and Putnam Associates. E.G.G. is employed by Transposon Therapeutics which is conducting clinical trials in PSP and C9-ALS/FTD (unrelated to this work); employment commenced after his contribution to this project. H.R. received consulting fees from Eisai and Genentech. L.T.G. receives research support from Genentech Inc. and a gift from Pivotal Life Science. L.T.G. received honoraria for educational activities from Medscape Education, Celdara Medical and consulting honoraria from Guidepoint Insights. W.W.S. is a paid consultant to Biogen Idec, Inc. and received speaker honoraria from Verge Genomics. The other authors declare no competing interests.
